These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1648432)

  • 41. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839.
    Edelman MJ; Hu C; Le QT; Donington JS; D'Souza WD; Dicker AP; Loo BW; Gore EM; Videtic GMM; Evans NR; Leach JW; Diehn M; Feigenberg SJ; Chen Y; Paulus R; Bradley JD
    J Thorac Oncol; 2017 Sep; 12(9):1413-1420. PubMed ID: 28629896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
    Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H
    JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
    Albain KS; Rusch VW; Crowley JJ; Rice TW; Turrisi AT; Weick JK; Lonchyna VA; Presant CA; McKenna RJ; Gandara DR
    J Clin Oncol; 1995 Aug; 13(8):1880-92. PubMed ID: 7636530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The lymphatic pathways of non-small cell lung cancer and their implication in curative irradiation treatment.
    Kiricuta IC; Mueller G; Stiess J; Bohndorf W
    Lung Cancer; 1994 Jul; 11(1-2):71-82. PubMed ID: 8081706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
    Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials.
    Cox JD; Pajak TF; Asbell S; Russell AH; Pederson J; Byhardt RW; Emami B; Roach M
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):493-8. PubMed ID: 8226140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Application of the 2007 lung cancer staging system by International Association for the Study of Lung Cancer].
    Wang J; Wu N; Zheng QF; Feng Y; Yan S; Yang Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 41(4):442-6. PubMed ID: 19727235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group.
    Sause W; Kolesar P; Taylor S IV; Johnson D; Livingston R; Komaki R; Emami B; Curran W; Byhardt R; Dar AR; Turrisi A
    Chest; 2000 Feb; 117(2):358-64. PubMed ID: 10669675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
    Schonewolf CA; Verma V; Post CM; Berman AT; Frick MA; Vachani A; Lin C; Simone CB
    Lung Cancer; 2018 Mar; 117():53-59. PubMed ID: 28800837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
    McAleer MF; Moughan J; Byhardt RW; Cox JD; Sause WT; Komaki R
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):802-8. PubMed ID: 19540055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.
    Suntharalingam M; Paulus R; Edelman MJ; Krasna M; Burrows W; Gore E; Wilson LD; Choy H
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):456-63. PubMed ID: 22543206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of surgery and radiation therapy for non-small cell carcinoma of the lung with mediastinal metastasis.
    Durci ML; Komaki R; Oswald MJ; Mountain CF
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):629-36. PubMed ID: 1651303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.
    Choi NC; Carey RW; Daly W; Mathisen D; Wain J; Wright C; Lynch T; Grossbard M; Grillo H
    J Clin Oncol; 1997 Feb; 15(2):712-22. PubMed ID: 9053497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of outcome between clinically staged, unresected superior sulcus tumors and other stage III non-small cell lung carcinomas treated with radiation therapy alone.
    Herbert SH; Curran WJ; Stafford PM; Rosenthal SA; McKenna WG; Hughes EN
    Cancer; 1992 Jan; 69(2):363-9. PubMed ID: 1309431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in Korea.
    Kim KH; Yang SS; Yoon YS; Lim SB; Yu CS; Kim JC
    Colorectal Dis; 2011 Aug; 13(8):e220-6. PubMed ID: 21689314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.
    Sun A; Hu C; Wong SJ; Gore E; Videtic G; Dutta S; Suntharalingam M; Chen Y; Gaspar LE; Choy H
    JAMA Oncol; 2019 Jun; 5(6):847-855. PubMed ID: 30869743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chest wall invasive non-small cell lung cancer: patterns of failure and implications for a revised staging system.
    Harpole DH; Healey EA; DeCamp MM; Mentzer SJ; Strauss GM; Sugarbaker DJ
    Ann Surg Oncol; 1996 May; 3(3):261-9. PubMed ID: 8726181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.